Elizondo de la Garza Oscar Balmore sold $2.3M of CX

Elizondo de la Garza Oscar Balmore (VP of Global Ent. Services) sold 212,680 shares of CEMEX SAB DE CV (CX) at $10.68 ($2.27M total) on 2026-08-19.

Original reporting
SEC EDGAR · Elizondo de la Garza Oscar Balmore
Published Aug 20, 2026, 11:12 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 20, 2026, 11:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$CX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The disclosed sale reduces the insider's ownership, which may be interpreted by investors as a bearish signal, though the size is modest relative to total shares outstanding.

02

Market read

Primary insider sale filing for a large-cap company; modest trading relevance.

03

What to watch

Potential tax planning or personal liquidity needs may drive the transaction.

Relevance 6/10Novelty 6/10Timing: after-market 2026-08-19

Background

SEC Form 4 filings disclose insider transactions; they are primary sources for insider activity.

Market effects

Minimal impact on the building materials sector; insider activity rarely moves the sector.

Limited to Mexican market perception of CEMEX governance.

Low; the filing is specific to CEMEX and does not affect broader markets.

Counterpoint

The sale could be unrelated to company outlook; insiders often diversify without negative implications.

Key entities

  • CEMEX SAB DE CV

    Global building materials company listed in the U.S. as CMX.

  • Elizondo de la Garza Oscar Balmore

    Vice President of Global Enterprise Services at CEMEX.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CXMedAI 8/10

Cemex Lifts Its 2026 Outlook as EBITDA Jumps 24%

Cemex reported second-quarter operating cash flow of US$1.02 billion, up 24%, as sales rose 12% to about US$4.1 billion, according to the company. Net income increased 9% to around US$347 million. Cemex raised its 2026 EBITDA-growth guidance to 16–17% from a prior high-single-digit outlook.

$CXMed

Cemex Sells Most of Its Colombia Business to Holcim

Cemex S.A.B. de C.V. said it will sell most of its Colombia operations to Holcim for about $485m, including a cement plant, a grinding mill and 20+ concrete/aggregates sites. Cemex expects total proceeds of about $555m, plus ~$70m from other asset sales, while keeping two plants in Colombia.

$CXMed

Cemex Sells Most of Its Colombia Business and Heads North

Cemex said it is divesting most of its Colombia business for about $555 million across several transactions, according to the company. Holcim will buy a cement plant, grinding mill and related assets for $485 million. Cemex expects the exit to close around year-end, subject to regulatory approval, as part of its portfolio rebalancing toward the U.S.

$CXMedAI 8/10

Cemex signs new US$3bn syndicated revolving credit facility

Cemex said it has signed a new five-year US$3bn syndicated revolving credit facility (the 2026 Credit Agreement) to fund general corporate purposes, including refinancing existing obligations for the parent and affiliates. The company said terms keep interest margins and commitments consistent with an investment-grade structure, with a 3.75x leverage cap and 2.75x coverage floor. Pricing is SOFR plus 85–137.5 bps depending on credit rating.